Dear Sir,

We thank Sodhi *et al*.\[[@ref1]\] for their interest and comments on our article "Causative fungi and treatment outcome of Dematiaceous fungal keratitis in North India."\[[@ref2]\] To answer the queries raised: the mean delay in patient presentation was 13.5 ± 14.5 days (95% confidence interval: 10.3--16.7 days; range: 1--90 days). Final visual acuity of patients with central location of ulcer was 0.96 ± 0.76 logMAR and of patients with paracentral/peripheral (combined as other group) ulcers was 0.51 ± 0.7 logMAR (*P* = 0.04; Independent sample *t*-test). In our study, the presence of hypopyon was associated with worse visual outcome \[[Table 1](#T1){ref-type="table"}\]. This univariate analysis was not presented in original article.

###### 

Univariate analysis of identified risk factors' analysis for predicting visual outcome

  Variable                 Category     Final VA logMAR   *P*
  ------------------------ ------------ ----------------- -------
  Gender                   Male         0.62±0.77         0.67
  Female                   0.71±0.72                      
  Age                      \<50 Years   0.99±0.79         0.01
  ≥50 Years                0.46±0.67                      
  Delay in presentation    ≤7 Days      0.80±0.76         0.1
  \>7 Days                 0.45±0.69                      
  Location of Ulcer        Central      0.96±0.76         0.04
  Paracentral/Peripheral   0.51±0.70                      
  Size of infiltrate       ≤4 mm        0.08±0.16         0.00
  \>4 mm                   0.93±0.76                      
  Presence of Hypopyon     Yes          1.31±0.68         0.002
  No                       0.50±0.68                      

Final visual acuity of the 3 patients using steroids at presentation was 20/20 in one case, 20/200 in second case. One patient was lost to follow-up. None of these patients required surgical management.

Indications for therapeutic penetrating keratoplasty were total infiltrate threatening to involve the limbus, corneal perforation of \>2 mm, and infiltrate not responding to intensive medication for 1-2 weeks. Graft size used was 9 mm in two cases, 10 mm in one case, and 11 mm in one case. Postoperatively, topical antifungals, cycloplegics, and analgesics were started for 2 weeks; after that, if there was no recurrence of infiltrate, steroids were started with discontinuation of antifungal therapy. We did not use intrastromal injections or oral antifungals. We saw a good response with topical therapy in the majority of cases. Hence, we do not suggest very early surgical intervention unless indicated.
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